Medical Device Development: Point-Counterpoint
Industry and government met to share common perspectives at the inaugural Cleveland Clinic Foundation's Medical Innovation Summit, held this past October, entitled "Bench to Boardroom to Patient Bedside: The Need for Speed." But barely below the surface were striking disagreements about where the fault lies for what all agreed is a disappointingly poor record of device innovation in recent years.
You may also be interested in...
GSK achieved a first-in-class market oncology launch in 2020, but will have to increase that hit rate in order to fulfil its blockbuster ambitions.
The two companies can now market their HER-2 targeting antibody-drug conjugate in its second tumor type as they look to expand beyond breast cancer.